DLBCL with CREBBP mutations shows depletion of tumor-infiltrating CD4+ T cells, while EP300 mutation is associated with M2 macrophage polarization, which induces an immune-suppressive TME [68]. The gene discussed is CD4; the disease is diffuse large B-cell lymphoma.